Locations
Cambridge, MA, USA · Cambridge, MA, USA
industry
Biotechnology · DeepTech · Health
Size
201-1000 employees
Stage
Other
founded in
2013
Editas Medicine is pioneering the development of CRISPR gene editing technologies to create transformative genomic medicines for serious diseases. The company focuses on discovering, developing, manufacturing, and commercializing innovative therapies that address the underlying genetic causes of diseases. With a robust pipeline of experimental medicines, Editas aims to achieve human proof of concept in the near future, positioning itself as a leader in the gene editing space. Their commitment to harnessing the potential of CRISPR technology differentiates them in the biotechnology sector, targeting a wide range of serious diseases and aiming to deliver durable solutions to patients globally.
Something looks off?On-site & Remote